nad has been researched along with Infections, Plasmodium in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Gulshan, M; Hikosaka, K; Inoue, SI; Kobayashi, F; Mahmood, A; Nakagawa, T; Yaku, K | 1 |
| Dessens, JT; Lasonder, E; Saeed, S; Sharma, V; Tremp, AZ | 1 |
| Ferraris, DM; Garavaglia, S; Gelardi, ELM; Miggiano, R; Rizzi, M | 1 |
| Alsaeed, AH; AlSalhi, MS; Devanesan, S; Ganesh, KM; Masilamani, V; Palled, S; Perinbam, K; Prasad, S; Ravikumar, M | 1 |
| Belinha, A; Estaquier, J; Gaifem, J; Laforge, M; Mesquita, I; Silvestre, R; Varela, P; Vergnes, B | 1 |
| Chan, HW; Chen, MJ; Cheu, KW; Coghi, P; Guo, ZF; Guo, ZH; Haynes, RK; Li, KY; Monti, D; Sinniah, K; Tang, MM; Witte, AB; Wong, HN | 1 |
| Cavaleyra, M; Monteny, N; Peltre, G; Riandey, MF; Sannier, C | 1 |
| Surolia, A; Surolia, N | 1 |
| Sanni, LA | 1 |
| Sherman, IW | 1 |
| Bowman, CM; Folkers, K; Porter, TH | 1 |
| Folkers, K; Porter, TH; Skelton, FS | 1 |
| Peterson, I; Sherman, IW; Tanigoshi, L; Ting, IP | 1 |
2 review(s) available for nad and Infections, Plasmodium
| Article | Year |
|---|---|
Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer.
Topics: Aldehyde Oxidoreductases; Animals; Antimalarials; Antitubercular Agents; Communicable Diseases; Drug Design; Drug Discovery; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Inhibins; Isoenzymes; Malaria; NAD; Neoplasms; Oxidoreductases; Tuberculosis | 2020 |
Exploring NAD+ metabolism in host-pathogen interactions.
Topics: Animals; Bacterial Infections; Bacterial Physiological Phenomena; Biosynthetic Pathways; Entamoeba; Entamoebiasis; Host-Pathogen Interactions; Humans; Leishmania; Leishmaniasis; Malaria; NAD; Plasmodium; Virus Diseases; Virus Physiological Phenomena | 2016 |
11 other study(ies) available for nad and Infections, Plasmodium
| Article | Year |
|---|---|
Nmnat3 deficiency in hemolytic anemia exacerbates malaria infection.
Topics: Anemia, Hemolytic; Animals; Child; Erythrocytes; Humans; Malaria; NAD; Nicotinamide-Nucleotide Adenylyltransferase | 2022 |
NAD(P) transhydrogenase has vital non-mitochondrial functions in malaria parasite transmission.
Topics: Animals; Malaria; Mitochondria; NAD; NADP; NADP Transhydrogenases | 2020 |
Fluorescence spectral diagnosis of malaria: a preliminary study.
Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Female; Flavin-Adenine Dinucleotide; Humans; Malaria; Male; NAD; Porphyrins; Sensitivity and Specificity; Spectrometry, Fluorescence; Tryptophan; Tyrosine; Young Adult | 2014 |
Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Interactions; Ferric Compounds; Flavin-Adenine Dinucleotide; Humans; Malaria; Methylene Blue; NAD; NADP; Oxidative Stress; Quinolines; Riboflavin | 2012 |
Lactate dehydrogenase as a marker of Plasmodium infection in malaria vector Anopheles.
Topics: Animals; Anopheles; Biomarkers; Female; Insect Vectors; Isoelectric Point; Isoenzymes; L-Lactate Dehydrogenase; Malaria; Mice; NAD; Plasmodium yoelii | 1996 |
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
Topics: Amino Acid Sequence; Animals; Antimalarials; Disease Models, Animal; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Malaria; Mice; Mice, Inbred BALB C; Molecular Sequence Data; NAD; Oxidoreductases; Plasmodium berghei; Plasmodium falciparum; Triclosan | 2001 |
The role of cerebral oedema in the pathogenesis of cerebral malaria.
Topics: Adult; Africa; Animals; Asia, Southeastern; Blood-Brain Barrier; Brain Edema; Cell Adhesion; Cerebrovascular Circulation; Child; Cytokines; Energy Metabolism; Humans; Hypoxia-Ischemia, Brain; Indoleamine-Pyrrole 2,3,-Dioxygenase; Malaria; Malaria, Cerebral; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Models, Biological; NAD; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Plasmodium berghei; Quinolinic Acid; Tryptophan Oxygenase; Vasodilation | 2001 |
Malic dehydrogenase heterogeneity in malaria (Plasmodium lophurae and P. berghei).
Topics: Animals; Electrophoresis; Enzymes; Hydrogen-Ion Concentration; Isoenzymes; Kinetics; Malaria; Malate Dehydrogenase; Mice; NAD; Oxaloacetates | 1966 |
Antimetabolites of coenzyme Q. 16. New alkylmercaptoquinones having antimalarial curative activity.
Topics: Animals; Antimalarials; Antimetabolites; Cattle; Chickens; Malaria; Mice; Mitochondria; NAD; Plasmodium berghei; Quinones; Succinate Dehydrogenase; Sulfides; Ubiquinone | 1973 |
Synthesis of new alkylamino- and alkylaminomethyl-5,8-quinolinequinones as inhibitors of coenzyme Q and as antimalarials.
Topics: Alkylation; Animals; Antimalarials; Culicidae; Malaria; Mice; NAD; Oxidoreductases; Quinolines; Quinones; Succinate Dehydrogenase; Ubiquinone | 1972 |
The glutamate dehydrogenase of Plasmodium lophurae (avian malaria).
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bird Diseases; Carbon Isotopes; Citric Acid Cycle; Electrophoresis; Erythrocytes; Gels; Glutamate Dehydrogenase; Glutamates; Hydrogen-Ion Concentration; Ketoglutaric Acids; Kinetics; Malaria; NAD; NADP; Oxidation-Reduction; Plasmodium; Proteins; Starch | 1971 |